Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1

Martin Reck, Tudor–Eliade Ciuleanu, Jong-Seok Lee, Michael Schenker, Bogdan Żurawski, Sang‐We Kim, Mauricio Mahave, Aurelia Alexandru, Solange Peters, Adam Płużański, Reyes Bernabe Caro, Helena Linardou, Jacobus A. Burgers, Makoto Nishio, Alex Martínez‐Martí, Koichi Azuma, Rita Axelrod, Luis Paz‐Ares, Suresh S. Ramalingam, Hossein Borghaei, Kenneth J. O’Byrne, Li Li, Judith Bushong, Ravi G. Gupta, Diederik J. Grootendorst, Laura J. Eccles, Julie R. Brahmer